Claudia S. Kielkopf

Claudia S. Kielkopf

Auto-generated profile, based on publicly available information

Claudia S. Kielkopf

Structural Biology of Molecular Machines Group, Protein Structure & Function Program, Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 June 2025 in Science Advances
Verified
Journal Article
Open access
VKVictor Klein-Sousa
Victor Klein-Sousa
ARAritz Roa-Eguiara
Aritz Roa-Eguiara
CKClaudia S. Kielkopf
Claudia S. Kielkopf
NSNicholas Sofos
Nicholas Sofos
NTNicholas Taylor
Nicholas Taylor
Bacteriophages use receptor-binding proteins (RBPs) to adhere to bacterial hosts, yet their sequence and structural diversity remain poorly understood. Tail fibers, a major class of RBPs, are elongated and flexible trimeric proteins, making their full-length structures difficult to resolve experimentally. Advances in deep learning–based protein structure prediction, such as AlphaFold2-multimer (AF2M) and ESMFold, provide opportunities for studying these challenging proteins. Here, we introduce RBPseg, a method that combines monomeric ESMFold predictions with a structural-based domain identification approach, to divide tail fiber sequences into manageable fractions for high-confidence modeling with AF2M. Using this approach, we generated complete tail fiber models, validated by single-particle cryo–electron microscopy of five fibers from three phages. A structural classification of 67 fibers identified 16 distinct classes and 89 domains, revealing patterns of modularity, convergence, divergence, and domain swapping. Our findings suggest that these structural classes represent at least 24% of the known tail fiber universe, providing key insights into their evolution and functionality.

6 October 2016 in The FEBS Journal
Verified
Journal Article
Open access
PDF file
LSLinnea Sandin
Linnea Sandin
LBLiza Bergkvist
Liza Bergkvist
SNSangeeta Nath
Sangeeta Nath
CKClaudia Kielkopf
Claudia Kielkopf
CJCamilla Janefjord
Camilla Janefjord
KKKatarina Kågedal
Katarina Kågedal
Genetic polymorphisms of immune genes that associate with higher risk to develop Alzheimer's disease (AD) have led to an increased research interest on the involvement of the immune system in AD pathogenesis. A link between amyloid pathology and immune gene expression was suggested in a genome‐wide gene expression study of transgenic amyloid mouse models. In this study, the gene expression of lysozyme, a major player in the innate immune system, was found to be increased in a comparable pattern as the amyloid pathology developed in transgenic mouse models of AD. A similar pattern was seen at protein levels of lysozyme in human AD brain and CSF, but this lysozyme pattern was not seen in a tau transgenic mouse model. Lysozyme was demonstrated to be beneficial for different Drosophila melanogaster models of AD. In flies that expressed Aβ1‐42 or AβPP together with BACE1 in the eyes, the rough eye phenotype indicative of toxicity was completely rescued by coexpression of lysozyme. In Drosophila flies bearing the Aβ1‐42 variant with the Arctic gene mutation, lysozyme increased the fly survival and decreased locomotor dysfunction dose dependently. An interaction between lysozyme and Aβ1‐42 in the Drosophila eye was discovered. We propose that the increased levels of lysozyme, seen in mouse models of AD and in human AD cases, were triggered by Aβ1‐42 and caused a beneficial effect by binding of lysozyme to toxic species of Aβ1‐42, which prevented these from exerting their toxic effects. These results emphasize the possibility of lysozyme as biomarker and therapeutic target for AD.

1 September 2018 in Journal of Structural Biology
Verified
Journal Article
Closed access
CKClaudia S. Kielkopf
Claudia S. Kielkopf
JLJason K.K. Low
Jason K.K. Low
YMYee-Foong Mok
Yee-Foong Mok
SBSurabhi Bhatia
Surabhi Bhatia
TPTony Palasovski
Tony Palasovski
SBSimon H.J. Brown
Simon H.J. Brown

5 January 2021 in Bioscience Reports
Verified
Journal Article
Open access
PDF file
CKClaudia S. Kielkopf
Claudia S. Kielkopf
AWAndrew E. Whitten
Andrew E. Whitten
BGBrett Garner
Brett Garner
SBSimon H.J. Brown
Simon H.J. Brown
Human apolipoprotein-D (apoD) is a glycosylated lipocalin that plays a protective role in Alzheimer’s disease due to its antioxidant function. Native apoD from human body fluids forms oligomers, predominantly a stable tetramer. As a lipocalin, apoD binds and transports small hydrophobic molecules such as progesterone, palmitic acid and sphingomyelin. Oligomerisation is a common trait in the lipocalin family and is affected by ligand binding in other lipocalins. The crystal structure of monomeric apoD shows no major changes upon progesterone binding. Here, we used small-angle X-ray scattering (SAXS) to investigate the influence of ligand binding and oxidation on apoD oligomerisation and conformation. As a solution-based technique, SAXS is well suited to detect changes in oligomeric state and conformation in response to ligand binding. Our results show no change in oligomeric state of apoD and no major conformational changes or subunit rearrangements in response to binding of ligands or protein oxidation. This highlights the highly stable structure of the native apoD tetramer under various physiologically relevant experimental conditions.

28 October 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
VKVictor Klein-Sousa
Victor Klein-Sousa
ARAritz Roa-Eguiara
Aritz Roa-Eguiara
CKClaudia S. Kielkopf
Claudia S. Kielkopf
NSNicholas Sofos
Nicholas Sofos
NTNicholas Taylor
Nicholas Taylor
Bacteriophages use receptor-binding proteins (RBPs) to adhere to bacterial hosts. Understanding the structure of these RBPs can provide insights into their target interactions. Tail fibers, a prominent type of RBP, are typically elongated, flexible, and trimeric proteins, making it challenging to obtain high-resolution experimental data of their full-length structures. Recent advancements in deep learning-based protein structure prediction, such as AlphaFold2-multimer (AF2M) and ESMfold, allow for the generation of high-confidence predicted models of complete tail fibers. In this paper, we introduce RBPseg, a method that combines monomeric ESMfold predictions with a novel sigmoid distance pair (sDp) protein segmentation technique. This method segments the tail fiber sequences into smaller fractions, preserving domain boundaries. These segments are then predicted in parallel using AF2M and assembled into a full fiber model. We demonstrate that RBPseg significantly improves AF2M v2.3.2 in terms of model confidence, running time, and memory usage. To validate our approach, we used single-particle cryo-electron microscopy to analyze five tail fibers from three phages of the BASEL collection. Additionally, we conducted a structural classification of 67 fibers and their domains, which identified 16 well-defined tail fiber classes and 89 domains. Our findings suggest the existence of modular fibers as well as fibers with different sequences and shared structure, indicating possible sequence convergence, divergence, and domain swapping. We further demonstrate that these structural classes account for at least 24% of the known tail fiber universe.

13 November 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
ESEva M. Steiner-Rebrova
Eva M. Steiner-Rebrova
RERooshanie N. Ejaz
Rooshanie N. Ejaz
CKClaudia S. Kielkopf
Claudia S. Kielkopf
MRMar Pérez Ruiz
Mar Pérez Ruiz
LMLeyre Marín-Arraiza
Leyre Marín-Arraiza
NTNicholas Taylor
Nicholas Taylor
Targeted delivery of therapeutics to specific cells is a major bottleneck towards personalized medicine. The extracellular injection system (eCIS) of Serratia entomophila , the antifeeding prophage (Afp), promises potential for drug delivery purposes. However, the precise mechanism of action, toxin location, and Afp loading remain unclear. Here, we reveal a minimal N-terminal signal peptide (NtSP) of the toxin Afp18, that plays a key role in toxin packing. By engineering fusion proteins, we demonstrate that Afp18’s NtSP can shuttle effectors for Afp loading. We packed non-eCIS effectors, including CRISPR-Cas protein CasΦ-2 from Biggiephage, and a human antimicrobial peptide, LL37, into Afp. Additionally, NtSPs from eCIS effectors of other species facilitate loading of CasΦ-2 into Afp. We observed cargo being packed inside the Afp tail tube through cryo-EM single particle analysis. The presented results enhance our understanding of eCIS toxin packing and contribute to their development as targeted delivery systems. Teaser: A novel use of the Afp nano injection system’s N-terminal signal peptide in targeted therapeutics delivery